These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1341 related items for PubMed ID: 26152656
21. BRAF mutation testing of thyroid fine-needle aspiration specimens enhances the predictability of malignancy in thyroid follicular lesions of undetermined significance. Adeniran AJ, Hui P, Chhieng DC, Prasad ML, Schofield K, Theoharis C. Acta Cytol; 2011; 55(6):570-5. PubMed ID: 22156468 [Abstract] [Full Text] [Related]
22. Role of ultrasonographic/clinical profile, cytology, and BRAF V600E mutation evaluation in thyroid nodule screening for malignancy: a prospective study. Rossi M, Buratto M, Bruni S, Filieri C, Tagliati F, Trasforini G, Rossi R, Beccati MD, Degli Uberti EC, Zatelli MC. J Clin Endocrinol Metab; 2012 Jul; 97(7):2354-61. PubMed ID: 22535974 [Abstract] [Full Text] [Related]
23. Analysis of BRAF(V600E) mutation and DNA methylation improves the diagnostics of thyroid fine needle aspiration biopsies. Zhang B, Liu S, Zhang Z, Wei J, Qu Y, Wu K, Yang Q, Hou P, Shi B. Diagn Pathol; 2014 Mar 03; 9():45. PubMed ID: 24588959 [Abstract] [Full Text] [Related]
24. [BRAF V600E mutation in papillary thyroid carcinoma: prevalence and detection in fine needle aspiration specimens]. Dujardin F, Pagès JC, Collin C, de Calan L, Lecomte P, Guyétant S. Ann Pathol; 2010 Aug 03; 30(4):252-62. PubMed ID: 20837233 [Abstract] [Full Text] [Related]
25. Value of immunohistochemistry in the detection of BRAF(V600E) mutations in fine-needle aspiration biopsies of papillary thyroid carcinoma. Zimmermann AK, Camenisch U, Rechsteiner MP, Bode-Lesniewska B, Rössle M. Cancer Cytopathol; 2014 Jan 03; 122(1):48-58. PubMed ID: 24039206 [Abstract] [Full Text] [Related]
26. Diagnostic utility of BRAFV600E mutation testing in thyroid nodules in elderly patients. Guerra A, Di Crescenzo V, Garzi A, Cinelli M, Carlomagno C, Pepe S, Zeppa P, Tonacchera M, Vitale M. BMC Surg; 2013 Jan 03; 13 Suppl 2(Suppl 2):S37. PubMed ID: 24267957 [Abstract] [Full Text] [Related]
31. BRAF(V600E) mutation analysis of liquid-based preparation-processed fine needle aspiration sample improves the diagnostic rate of papillary thyroid carcinoma. Chang H, Lee H, Yoon SO, Kim H, Kim A, Kim BH. Hum Pathol; 2012 Jan 03; 43(1):89-95. PubMed ID: 21774961 [Abstract] [Full Text] [Related]
32. Cytomorphologic features in thyroid nodules read as "suspicious for malignancy" on cytology may predict thyroid cancers with the BRAF mutation. Kwon HJ, Kim EK, Kwak JY. Pathol Res Pract; 2015 Sep 03; 211(9):671-6. PubMed ID: 26187369 [Abstract] [Full Text] [Related]
36. BRAF analysis by fine needle aspiration biopsy of thyroid nodules improves preoperative identification of papillary thyroid carcinoma and represents a prognostic factor. A mono-institutional experience. Pelizzo MR, Boschin IM, Barollo S, Pennelli G, Toniato A, Zambonin L, Vianello F, Piotto A, Ide EC, Pagetta C, Sorgato N, Torresan F, Girelli ME, Nacamulli D, Mantero F, Mian C. Clin Chem Lab Med; 2011 Feb 03; 49(2):325-9. PubMed ID: 21175381 [Abstract] [Full Text] [Related]
37. [Clinical role of BRAF V600E mutation testing in thyroid nodules]. Wan H, Zhang B, Wang Y, Xiao T, Guo H, Liu W, Yan D, Xu Z, Tang P. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2014 Jun 03; 49(6):468-72. PubMed ID: 25241863 [Abstract] [Full Text] [Related]